In highly invasive breast cancer, betulinic acid induces Bip/GRP78 overexpression and activates PERK, leading to eIF2α phosphorylation, which inhibits β-catenin expression and subsequently represses c-Myc-driven glycolysis [125]. The gene discussed is MYC; the disease is breast cancer.